Updates

Tweets by @cellcentric

All our updates and events through tweets

How we operate our clinical operations function, flexibly and expediently... New blog: cellcentric.com/updates/blog-n… pic.twitter.com/ARU9xDd4YY

Great to have Laura joining the clinical ops team today. Clinical studies of CCS1477 continue to ramp up; prostate cancer, haems, targeted tumours. pic.twitter.com/dpMziZI3nQ

New paper by Yu et al., in Molecular Cell. Androgen Receptor co-activation complexes including p300: cell.com/molecular-cell… pic.twitter.com/xivLnWKr27

Welcome also to Fiona, who takes on GCP quality assurance responsibilities. CCS1477, first-in-class p300/CBP inhibitor, in Phase I/II clinical trials. pic.twitter.com/O8gy4npkKC

Delighted to welcome Gail to the CellCentric team. Clinical trials of CCS1477 are carefully ramping up again, as Covid-19 measures ease. cellcentric.com/company/team/ pic.twitter.com/5wdm5dno1X

Great to have new patients being dosed this week with CCS1477. Clinical trials now set to re-establish and expand. Many thanks Marsden/ICR and Leicester. pic.twitter.com/RnrHE8cNrO

Our locations

Get in touch

Contact us